✦ LIBER ✦

1122 ORAL Paclitaxel poliglumex vs. gemcitabine or vinorelbine for the treatment of performance status (PS) 2 patients with chemotherapy-naïve advanced non-small cell lung cancer (NSCLC): the STELLAR 4 phase III study

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-104 XYOTAXT™ vs. gemcitabine or vinore

✍ O'Brien, M.; Sandler, A.; Popovich, A.; Ganchev, H.; Bogdanova, N.; Miziara, J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

O-101 XYOTAX™/carboplatin vs paclitaxel/

✍ Langer, C.; O'Byrne, K.; Ross, H.; Socinski, M.; Szczesna, A.; Dediu, M.; Orlov, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB

PS13 Late breaking Paclitaxel poliglumex

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Randomized phase III trial of gemcitabin

✍ Morabito, Alessandro; Gebbia, Vittorio; Di Maio, Massimo; Cinieri, Saverio; Viga 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 930 KB

P.40 Oral vinorelbine and gemcitabine (o

✍ Vamvakas, L.; Karampeazis, A.; Agelaki, S.; Agelidou, A.; Kotsakis, A.; Kakolyri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB